Found: 1
Select item for more details and to access through your institution.
Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 6, p. 856, doi. 10.1007/s12185-022-03438-1
- By:
- Publication type:
- Article